Skip to main content
Erschienen in: Head and Neck Pathology 3/2009

01.09.2009 | Head and Neck Pre-Meeting of the 22nd European Congress of Pathology

Head and Neck Squamous Cell Carcinoma in the Young: A Spectrum or a Distinct Group? Part 2

verfasst von: M. Toner, E. M. O’Regan

Erschienen in: Head and Neck Pathology | Ausgabe 3/2009

Einloggen, um Zugang zu erhalten

Abstract

A recent increase in the number of young patients (often nonsmokers) developing head and neck squamous cell carcinoma (HNSCC) has been documented, however, there remains no clear evidence to support the significance of any single determinant. The typical HNSCC arises as a result of a multistep process and the progression model involving multiple genetic and epigenetic events is thought to be relatively consistent. While the progression model itself may be consistent, detection methods used in genomic studies are variable and all have their limitations. This article reviews changes at a molecular level in the typical HNSCC patient (the over 40 year old male smoker) and compares the profile to that of the young adult with HNSCC. Human papillomavirus infection with high risk types 16 and 18 has widely been reported as one of the prominent mechanisms behind the development of oropharyngeal cancer. A review of recent studies in relation to HPV and HNSCC is undertaken in this article, in an effort to examine the role that HPV plays in the development of HNSCC in young adults.
Literatur
1.
Zurück zum Zitat Califano J, Van der Riet P, Westra W, Nawroz H, Clayman G, Piantadosi S, et al. Genetic progression model for head and neck cancer; implications for field cancerization. Cancer Res. 1996;56:2488–92.PubMed Califano J, Van der Riet P, Westra W, Nawroz H, Clayman G, Piantadosi S, et al. Genetic progression model for head and neck cancer; implications for field cancerization. Cancer Res. 1996;56:2488–92.PubMed
2.
Zurück zum Zitat Hermsen MAJA, Joenje H, Arwert F. Assessment of chromosomal gains and losses in oral squamous cell carcinoma by CGH. Oral Oncology. 1997;33:414–8.PubMedCrossRef Hermsen MAJA, Joenje H, Arwert F. Assessment of chromosomal gains and losses in oral squamous cell carcinoma by CGH. Oral Oncology. 1997;33:414–8.PubMedCrossRef
3.
Zurück zum Zitat Garnis C, Baldwin C, Zhang L, Rosin MP, Lam WL. Use of complete coverage array comparative genomic hybridisation to define copy number alterations on chromosome 3p in oral squamous cell carcinomas. Cancer Res. 2003;63(24):8582–5.PubMed Garnis C, Baldwin C, Zhang L, Rosin MP, Lam WL. Use of complete coverage array comparative genomic hybridisation to define copy number alterations on chromosome 3p in oral squamous cell carcinomas. Cancer Res. 2003;63(24):8582–5.PubMed
4.
Zurück zum Zitat O’Regan EM, Toner ME, Smyth PC, Finn SP, Timon C, Cahill S, et al. Distinct array comparative genomic hybridization profiles in oral squamous cell carcinoma occurring in young patients. Head Neck. 2006;28(4):330–8.PubMedCrossRef O’Regan EM, Toner ME, Smyth PC, Finn SP, Timon C, Cahill S, et al. Distinct array comparative genomic hybridization profiles in oral squamous cell carcinoma occurring in young patients. Head Neck. 2006;28(4):330–8.PubMedCrossRef
5.
Zurück zum Zitat Koch WM, Lango M, Sewell D, Zahurak M, Sidransky D. Head and neck cancer in nonsmokers: a distinct clinical and molecular entity. Laryngoscope. 1999;109(10):1544–51.PubMedCrossRef Koch WM, Lango M, Sewell D, Zahurak M, Sidransky D. Head and neck cancer in nonsmokers: a distinct clinical and molecular entity. Laryngoscope. 1999;109(10):1544–51.PubMedCrossRef
6.
Zurück zum Zitat Ryott M, Wangsa D, Heselmeyer-Haddad K, Lindholm J, Elmberger G, Auer G, et al. EGFR protein overexpression and gene copy number increases in oral tongue squamous cell carcinoma. Eur J Cancer. 2009;45(9):1700–8. Epub 2009 Mar 28.PubMedCrossRef Ryott M, Wangsa D, Heselmeyer-Haddad K, Lindholm J, Elmberger G, Auer G, et al. EGFR protein overexpression and gene copy number increases in oral tongue squamous cell carcinoma. Eur J Cancer. 2009;45(9):1700–8. Epub 2009 Mar 28.PubMedCrossRef
7.
Zurück zum Zitat De Paula AM, Souza LR, Farias LC, Corrêa GT, Fraga CA, Eleutério NB, Silveira AC, Santos FB, Haikal DS, Guimarães AL, Gomez RS. Analysis of 724 cases of primary head and neck squamous cell carcinoma (HNSCC) with a focus on young patients and p53 immunolocalization. Oral Oncol. 2009 [Epub ahead of print]. De Paula AM, Souza LR, Farias LC, Corrêa GT, Fraga CA, Eleutério NB, Silveira AC, Santos FB, Haikal DS, Guimarães AL, Gomez RS. Analysis of 724 cases of primary head and neck squamous cell carcinoma (HNSCC) with a focus on young patients and p53 immunolocalization. Oral Oncol. 2009 [Epub ahead of print].
8.
Zurück zum Zitat Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, et al. Evidence for a causal association between human papillomavirus and a subset. J Natl Cancer Inst. 2000;92(9):709–20.PubMedCrossRef Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, et al. Evidence for a causal association between human papillomavirus and a subset. J Natl Cancer Inst. 2000;92(9):709–20.PubMedCrossRef
9.
Zurück zum Zitat Reed AL, Califano J, Cairns P, Westra WH, Jones RM, Koch W, et al. High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. Cancer Res. 1996;56:3630–3.PubMed Reed AL, Califano J, Cairns P, Westra WH, Jones RM, Koch W, et al. High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. Cancer Res. 1996;56:3630–3.PubMed
10.
Zurück zum Zitat Mork J, Lie AK, Glattre E, Hallmans G, Jellum E, Koskela P, et al. Human papillomavirus infection as a risk factor for squamous cell carcinoma of the head and neck. N Eng J Med. 2001;344:1125–31.CrossRef Mork J, Lie AK, Glattre E, Hallmans G, Jellum E, Koskela P, et al. Human papillomavirus infection as a risk factor for squamous cell carcinoma of the head and neck. N Eng J Med. 2001;344:1125–31.CrossRef
Metadaten
Titel
Head and Neck Squamous Cell Carcinoma in the Young: A Spectrum or a Distinct Group? Part 2
verfasst von
M. Toner
E. M. O’Regan
Publikationsdatum
01.09.2009
Verlag
Humana Press Inc
Erschienen in
Head and Neck Pathology / Ausgabe 3/2009
Elektronische ISSN: 1936-0568
DOI
https://doi.org/10.1007/s12105-009-0137-y

Weitere Artikel der Ausgabe 3/2009

Head and Neck Pathology 3/2009 Zur Ausgabe

Head and Neck Pre-Meeting of the 22nd European Congress of Pathology

Head and Neck Squamous Cell Carcinoma in the Young: A Spectrum or a Distinct Group? Part 1

Head and Neck Pre-Meeting of the 22nd European Congress of Pathology

Metastases to the Head and Neck: An Overview

Head and Neck Pre-Meeting of the 22nd European Congress of Pathology

Olfactory Neuroblastoma

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …